UCB reports success in phase 3 study of fenfluramine for CDD

30th June 2025 Uncategorised 0

Positive trial results offer hope for those with ultra-rare epileptic disorder

More: UCB reports success in phase 3 study of fenfluramine for CDD
Source: News